Steve Coen's Class A Securities Sale Plan

The filing details Steve Coen's plan to sell Class A securities of Ginkgo Bioworks Holdings, Inc. The securities were acquired through restricted stock vesting as part of compensation. The plan includes the sale of 5,609 units with an aggregate market value of $84,135.00, scheduled for approximately October 21, 2025. Additionally, Coen sold 310 units of Class A securities on August 22, 2025, for $3,842.79. The filing also lists the acquisition dates and amounts of the securities to be sold, which were acquired between May 1, 2024, and September 11, 2024. The filing is signed by Jennifer Ruchti, a representative of Fidelity Brokerage Services LLC, acting as attorney-in-fact for Steve Coen.